In patients with CAPS treated with IL-1-blockers, S100A12 and S100A8/S100A9 correlate with inflammatory activity and decline rapidly along with a normalization of neutrophil counts (92). This evidence concerns the gene S100A12 and cryopyrin-associated periodic syndrome.